0 Comments
0 Shares
389 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Heart Failure Therapy: The Expanding Market for Beta-Blocker Medications Like CarvedilolHeart failure is a chronic, progressive condition that affects millions of people worldwide and represents a significant economic burden on healthcare systems. Beta-blocker medications are a cornerstone of heart failure therapy, proven to reduce mortality, hospitalizations, and improve quality of life. Among these, carvedilol is a prominent agent with a well-established role in managing both...0 Comments 0 Shares 144 Views 0 Reviews
-
How Rising Healthcare Expenditure and Awareness Are Driving India's Heart Failure Drugs MarketThe India heart failure drugs market is experiencing significant growth, driven by rising healthcare expenditure, increasing awareness about heart health, and a growing prevalence of cardiovascular conditions. With an estimated 1.3 million individuals diagnosed with heart failure annually in India, the demand for effective therapies has never been higher. The market, valued at USD 1,461.5...0 Comments 0 Shares 111 Views 0 Reviews
-
Asia-Pacific Heart Failure Software Market Dynamics: Key Drivers and RestraintsAccording to the latest report published by Data Bridge Market Research, the Asia-Pacific Heart Failure Software Market CAGR Value The Asia-Pacific Heart Failure Software market size was valued at USD 990.03 Million in 2025 and is expected to reach USD 1601.93 Million by 2033, at a CAGR of 6.20% during the forecast period This Asia-Pacific...0 Comments 0 Shares 136 Views 0 Reviews
-
Asia-Pacific Heart Failure Software Market Overview: Key Drivers and ChallengesKey Drivers Impacting Executive Summary Asia-Pacific Heart Failure Software Market Market Size and Share CAGR Value The Asia-Pacific Heart Failure Software market size was valued at USD 990.03 Million in 2025 and is expected to reach USD 1601.93 Million by 2033, at a CAGR of 6.20% during the forecast period The report explains the vital developments...0 Comments 0 Shares 278 Views 0 Reviews
-
Asia-Pacific Heart Failure Software Market Overview: Key Drivers and ChallengesAccording to the latest report published by Data Bridge Market Research, the Asia-Pacific Heart Failure Software Market This client-centric, leading edge and truthful Asia-Pacific Heart Failure Software Market report is generated with the experience of skilful, enthusiastic and innovative team. The numerical data, statistical data, facts and figures are represented very...0 Comments 0 Shares 87 Views 0 Reviews
-
Asia-Pacific Heart Failure Software Market Trends, Insights and Future OutlookExecutive Summary Asia-Pacific Heart Failure Software Market Size and Share Analysis Report CAGR Value The Asia-Pacific Heart Failure Software market size was valued at USD 990.03 Million in 2025 and is expected to reach USD 1601.93 Million by 2033, at a CAGR of 6.20% during the forecast period This Asia-Pacific Heart Failure Software Market report is...0 Comments 0 Shares 203 Views 0 Reviews
-
Asia-Pacific Heart Failure Software Market: Insights, Key Players, and Growth AnalysisRegional Overview of Executive Summary Asia-Pacific Heart Failure Software Market by Size and Share CAGR Value Data Bridge Market Research analyses that the market is growing with a CAGR of 6.2% in the forecast period of 2021 to 2028 and is expected to reach USD 1,185.83 million by 2028 The market report also contains the drivers and restraints for the Asia-Pacific Heart Failure...0 Comments 0 Shares 519 Views 0 Reviews
-
Cardiac Resynchronization Therapy Market – Advanced Devices Support Heart Failure ManagementThe cardiac resynchronization therapy, or CRT, market is growing as the prevalence of heart failure rises and healthcare providers adopt advanced implantable devices to help improve cardiac coordination in selected patients. The market was valued at USD 4.22 billion in 2024 and is projected to reach USD 7.7 billion by 2032, growing at a CAGR of 7.8%. 1180 Heart failure occurs when the heart...0 Comments 0 Shares 120 Views 0 Reviews
-
Cardioselective Beta Blockers Market: Cardiovascular Therapeutics, Hypertension and Heart Failure Management, and Drug Formulation AnalysisThe Global Cardioselective Beta Blockers Market is a cornerstone of the pharmaceutical industry’s cardiovascular division, representing a refined class of medications specifically designed to treat heart-related conditions with greater precision than their non-selective predecessors. In 2025, these medications remain a frontline defense against the growing global burden of hypertension,...0 Comments 0 Shares 1K Views 0 Reviews
-
Chronic Heart Failure Devices Market Trends and Forecast 2034: Drivers, Challenges, and Future OutlookChronic heart failure devices incorporate advanced engineering, digital connectivity, and intelligent monitoring capabilities to improve the diagnosis and treatment of heart failure. Modern systems provide real time physiological data that allows healthcare professionals to evaluate patient status remotely and make informed clinical decisions. Global Chronic Heart Failure Devices Market Growth...0 Comments 0 Shares 197 Views 0 Reviews
-
Chronic Heart Failure Devices Market: Size, Share, Growth, and Trends Forecast to 2034The Global Chronic Heart Failure (CHF) Devices Market is on a firm upward trajectory, with projections indicating a compound annual growth rate (CAGR) of 7.9% between 2026 and 2034. This sustained growth reflects the increasingly urgent need for innovative cardiac care solutions as cardiovascular diseases continue to be one of the world's leading causes of mortality. According to the World...0 Comments 0 Shares 385 Views 0 Reviews
-
Angina Pectoris Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033According to the latest report published by Data Bridge Market Research, the Angina Pectoris Drugs Market The global angina pectoris drugs market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 17.09 billion by 2033, at a CAGR of 5.50% during the forecast period The universal Angina Pectoris Drugs Market report has...0 Comments 0 Shares 9K Views 0 Reviews
-
Coronary Artery Disease Market Size, Industry Trends, and Growth Forecast to 2032According to the latest report published by Data Bridge Market Research, the Coronary Artery Disease Market The global coronary artery disease market was valued at USD 24.97 million in 2024 and is expected to reach USD 49.25 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 8.86% primarily driven by the...0 Comments 0 Shares 8K Views 0 Reviews
-
Coronary Artery Disease Market Size, Industry Trends, and Growth Forecast to 2032According to the latest report published by Data Bridge Market Research, the Coronary Artery Disease Market The global coronary artery disease market was valued at USD 24.97 million in 2024 and is expected to reach USD 49.25 billion by 2032 Global Coronary Artery Disease Market document gives important, thoughtful and meaningful market insights for business by...0 Comments 0 Shares 7K Views 0 Reviews
-
Coronary Artery Disease Market Size, Industry Trends, and Growth Forecast to 2032According to the latest report published by Data Bridge Market Research, the Coronary Artery Disease Market The global coronary artery disease market was valued at USD 24.97 million in 2024 and is expected to reach USD 49.25 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 8.86% primarily driven by the...0 Comments 0 Shares 7K Views 0 Reviews
-
Europe Heart Failure Software Market: Size, Share, and Future GrowthLatest Insights on Executive Summary Europe Heart Failure Software Market Share and Size CAGR Value Data Bridge Market Research analyses that the market is growing with a CAGR of 5.1% in the forecast period of 2021 to 2028 and is expected to reach USD 1,433.32 million by 202 The market insights gained through this keyword market research analysis report facilitate a more defined...0 Comments 0 Shares 526 Views 0 Reviews
-
Future Outlook for the Medications for Heart Failure Market Through 2035The rising prevalence of cardiovascular diseases and the growing burden of chronic heart failure are driving steady growth in the Medications For Heart Failure Market. Heart failure medications—including ACE inhibitors, beta blockers, diuretics, angiotensin receptor blockers (ARBs), mineralocorticoid receptor antagonists, and newer therapies such as SGLT2 inhibitors and angiotensin...0 Comments 0 Shares 106 Views 0 Reviews
-
Heart Failure Drugs Market Competitive Landscape: Leading Companies and Drug Development TrendsNEWARK, Del., Aug. 20, 2026 — The global Heart Failure Drugs Market is expanding as healthcare providers increasingly adopt guideline-directed medical therapy and earlier pharmacological intervention for patients with heart failure. According to Future Market Insights (FMI), the market is projected to grow from USD 18.8 billion in 2026 to USD 37.0 billion by 2036, registering a 7.0% CAGR...0 Comments 0 Shares 65 Views 0 Reviews
-
Intravascular Microaxial LVAD Devices Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Intravascular Microaxial LVAD Devices Market The global intravascular microaxial LVAD devices market size was valued at USD 594.00 million in 2024 and is expected to reach USD 2,071.58 million by 2032, at a CAGR of 16.90% during the forecast period The comprehensive...0 Comments 0 Shares 2K Views 0 Reviews
-
Middle East and Africa Heart Failure Software Market Trends, Insights and Future OutlookExecutive Summary Middle East and Africa Heart Failure Software Market Size and Share Analysis Report CAGR Value Data Bridge Market Research analyses that the market is growing with a CAGR of 3.09% in the forecast period of 2021 to 2028 and is expected to reach USD 104.27 million by 2028. This Middle East and Africa Heart Failure Software Market report is useful in evaluating the...0 Comments 0 Shares 704 Views 0 Reviews
-
North America Heart Failure Software Market Overview: Key Drivers and ChallengesExecutive Summary North America Heart Failure Software Market: Share, Size & Strategic Insights CAGR Value The North America Heart Failure Software report makes available a thoughtful overview of product specification, technology, product type and production analysis, taking into account major factors such as revenue, Cost, gross, and Gross Margin. The report is sure to offer brilliant...0 Comments 0 Shares 448 Views 0 Reviews
More Results
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali